Imunon

IMNNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.024 M

$1.43 +5.15%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

$14.5M

#1971 by earnings

Shares outstanding

5,611,403

Latest filing cover page

P/E ratio

0.6

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#441Ensysce BiosciencesENSC$8.19M
#442SoligenixSNGX$8.10M
#443ImunonIMNN$8.02M
#444Skye BioscienceSKYE$7.88M
#445LongeveronLGVN$7.81M

What if Imunon were worth as much as…

Open the what-if tool →

Gold $30.3T

$5,395,096

Per share 3,772,794× higher

Bitcoin $1.72T

$306,483.74

Per share 214,324× higher

Nvidia $5.48T

$976,557.59

Per share 682,907× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Imunon are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.